Cyclopentyl modulators of chemokine receptor activity

Details for Australian Patent Application No. 2001283345 (hide)

Owner Merck & Co., Inc.

Inventors Pasternak, Alexander; Parsons, William H; Butora, Gabor; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-B-2001283345

PCT Pub. Number WO02/13824

Priority 60225923 17.08.00 US

Filing date 13 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 24 March 2005

International Classifications

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

C07D 211/32 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

24 March 2005 Application Accepted

  Published as AU-B-2001283345

21 July 2005 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001283346

2001283344